Market capitalization | JPY518.23b |
Enterprise Value | JPY570.34b |
P/E (TTM) P/E ratio | 34.56 |
EV/Sales (TTM) EV/Sales | 0.44 |
P/S ratio (TTM) P/S ratio | 0.40 |
P/B ratio (TTM) P/B ratio | 2.08 |
Dividend yield | 1.44% |
Last dividend (FY25) | JPY36.00 |
Revenue growth (TTM) Revenue growth | 5.56% |
As a Free StocksGuide user, you can view scores for all 6,780 stocks worldwide.
11 Analysts have issued a Welcia forecast:
11 Analysts have issued a Welcia forecast:
Feb '25 |
+/-
%
|
||
Revenue | 1,285,005 1,285,005 |
6%
6%
|
|
Gross Profit | 379,941 379,941 |
4%
4%
|
|
EBITDA | 62,658 62,658 |
7%
7%
|
EBIT (Operating Income) EBIT | 36,410 36,410 |
16%
16%
|
Net Profit | 14,957 14,957 |
43%
43%
|
In millions JPY.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Welcia Holdings Co., Ltd. engages in the management of its subsidiaries and group companies which are in the pharmaceutical business. Its core business deals with the operation of drug store chains which offer prescription drugs and pharmaceuticals, sanitation and nursing care items, health food products, baby supplies, cosmetics, and household sundries. The company was founded on September 1, 2008 and is headquartered in Tokyo, Japan.
Head office | Japan |
CEO | Takamitsu Ikeno |
Founded | 2008 |
Website | www.welcia.co.jp |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.